Furthermore, elevated leptin levels are correlated with production of vascular endothelial growth factor (VEGF) 10, leading to angiogenesis, which may lead to resistance to VEGF-targeted drugs, such as bevacizumab in obesity-associated cases. This evidence concerns the gene VEGFA and obesity due to melanocortin 4 receptor deficiency.